Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.

NCT06294015 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT06294015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06294015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
Lead sponsor
Université de Sherbrooke
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2024
Completion date
April 30, 2026
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

corneal disease, corneal epitheliopathy, dry eye, glaucoma